Tullis — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
HealthtechCarlsbad, US
Terry M. Rich(Executive Officer, Director)Craig Hunsaker(Executive Officer)John Allen(Executive Officer)Jeffrey Black(Executive Officer)Patrick S. Miles(Executive Officer, Director)
BoardMortimer Berkowitz III(Director)
Board seatJames L. L. Tullis· per SEC Form D · $168M raise · filed Dec 2020
electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions.
BiotechDigital HealthHardwareHealthtechMedical DevicesBasking Ridge, US
JP Errico(Executive Officer)Brian Posner(Executive Officer)Daniel S. Goldberger(Executive Officer, Director)Peter Staats(Director)Frank Amato(Executive Officer)
BoardTrevor Moody(Director)
Board seatJames L.L. TullisJames Tullis· per SEC Form D · $1.7M raise · filed Apr 2020
Co-investorsFoothill VenturesTullis Health Investors
Hyperion DeFi is a U.S.
BiotechCrypto & Web3FintechHealthtechLaguna Hills, US
Michael Rowe(Executive Officer, Director)Hyunsu Jung(Chief Executive Officer)BARRY BUTLER(Executive Officer)David(Chief Financial Officer)TSONTCHO IANCHULEV(Executive Officer, Director)
Board seatCurt LaBelle· per SEC Form D · $6M raise · filed Apr 2020
Co-investorsEshelman Ventures, LLC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.